Skip to content
Dx

ICD-10-CM 2027 diagnosis code

B60.13Keratoconjunctivitis due to Acanthamoeba

✓ Billable / specific

B60.13 is a valid, billable ICD-10-CM code for keratoconjunctivitis due to acanthamoeba. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.

Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About B60.13

B60.13 is the ICD-10-CM diagnosis code for keratoconjunctivitis due to Acanthamoeba. It belongs to category B60 (other protozoal diseases, not elsewhere classified), block B50-B64 (protozoal diseases) and chapter 1 (certain infectious and parasitic diseases). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within B60.1 (Acanthamebiasis), B60.13 is specifically for keratoconjunctivitis due to Acanthamoeba. Related codes cover unspecified (B60.10), meningoencephalitis due to Acanthamoeba (culbertsoni) (B60.11), conjunctivitis due to Acanthamoeba (B60.12) and other acanthamebic disease (B60.19).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent, relative weight 1.2471) and DRG 125 (Other Disorders of the Eye without MCC, relative weight 0.7702), in MDC 02 (Diseases and Disorders of the Eye), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 136.21 (specific infection due to acanthamoeba) and 370.8 (other forms of keratitis).

Notes that apply from higher levels

Instructions written at a parent level also apply to B60.13.

› From B60 Other protozoal diseases, not elsewhere classified
Excludes1
  • cryptosporidiosis (A07.2)
  • intestinal microsporidiosis (A07.8)
  • isosporiasis (A07.3)

Broader instructions also apply from B50-B64 Protozoal diseases and Chapter 1: Certain infectious and parasitic diseases.

Alphabetic index entries

3 entries

Terms in the official ICD-10-CM index that lead to B60.13.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

ICD-9-CM equivalent

Converter →
  • 136.21Specific infection due to acanthamoebaapproximate, combination
  • 370.8Other forms of keratitisapproximate, combination

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about B60.13

Is B60.13 billable?

Yes. B60.13 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can B60.13 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict B60.13 as a principal diagnosis.

Is B60.13 a CC or MCC?

No. B60.13 is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does B60.13 group to?

B60.13 is used in the MS-DRG v44.0 logic for MS-DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent) and MS-DRG 125 (Other Disorders of the Eye without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for B60.13?

The CMS General Equivalence Mappings map B60.13 to ICD-9-CM 136.21 and 370.8.